Cargando…
Regulatory B cells in myasthenia gravis are differentially affected by therapies
We analyzed the number and functionality of regulatory B (Breg) cells in well‐defined myasthenia gravis patients. We first showed a decreased number of circulating CD19(+) CD24(++) CD38(++) Breg cells and an altered functionality of Breg cells in untreated myasthenia gravis patients. Next, we demons...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243377/ https://www.ncbi.nlm.nih.gov/pubmed/30480034 http://dx.doi.org/10.1002/acn3.645 |